Share Price and Basic Stock Data
Last Updated: November 4, 2025, 12:14 am
| PEG Ratio | 0.00 |
|---|
Analyst Insight & Comprehensive Analysis
Business Overview and Revenue Trends
Hindustan Agrigenetics Ltd, operating in the floriculture sector, reported a share price of ₹60.0 and a market capitalization of ₹26.4 Cr. The company’s sales figures have remained modest in recent quarters, with revenues of ₹0.04 Cr recorded in June 2022, June 2023, and subsequent quarters, while other quarters showed negligible sales, including ₹0.00 Cr in September 2022 and March 2023. Over the years, total sales for FY 2025 stood at ₹0.08 Cr, a slight increase from ₹0.07 Cr in FY 2024. The company’s operating profit margins (OPM) have fluctuated dramatically, showing a negative margin of -914.29% in FY 2023, improving to -428.57% in FY 2024, and further declining to -1,275.00% in FY 2025. This erratic performance underscores challenges in revenue generation and cost management, reflecting a sector where profitability remains elusive and revenue stability is crucial for sustainability.
Profitability and Efficiency Metrics
Hindustan Agrigenetics Ltd reported a net profit of ₹0.04 Cr for the trailing twelve months, which translates to a return on equity (ROE) of 3.61% and a return on capital employed (ROCE) of 3.53%. However, these figures are significantly low compared to industry standards, indicating inefficiencies in capital utilization. The interest coverage ratio (ICR) stood at -23.78x, highlighting the company’s inability to cover interest expenses with its current earnings. Operating profit for FY 2025 further deteriorated, with a loss of ₹1.02 Cr, following a similar trend from the previous years with losses recorded in FY 2023 and FY 2024. The company’s ability to control operational costs and improve revenue generation is critical, particularly as the operating profit margin (OPM) remains negative and significantly below typical sector ranges, which usually hover around positive margins for sustainable growth.
Balance Sheet Strength and Financial Ratios
The balance sheet of Hindustan Agrigenetics Ltd shows a total asset value of ₹12.40 Cr as of March 2025, with no borrowings reported, indicating a debt-free status. The company maintained reserves of ₹7.62 Cr, which reflects a substantial improvement from negative reserves in previous years. The company’s current and quick ratios are extraordinarily high at 330.73, suggesting a strong liquidity position, which is atypical for the sector. The price-to-book value (P/BV) ratio stood at 2.46x, indicating that the market values the company at a premium over its book value, which can be a positive sign for investors despite the underlying profitability issues. However, the overall financial ratios suggest that while the company is not leveraged, its efficiency in generating returns from its assets and equity remains a significant concern that needs addressing.
Shareholding Pattern and Investor Confidence
The shareholding pattern of Hindustan Agrigenetics Ltd reveals a diverse ownership structure, with public shareholders holding 81.89% as of June 2025. Promoters own a reduced stake of 8.18%, down from 29.42% in previous quarters, indicating potential concerns about management confidence in the company’s future. Foreign institutional investors (FIIs) and domestic institutional investors (DIIs) hold a minor share of 0.43% and 1.08%, respectively, which reflects low institutional interest. The number of shareholders has increased to 7,454, suggesting a growing retail investor base, although the overall confidence appears tempered given the company’s historical performance metrics. This composition may indicate a cautious approach from institutional investors, who typically seek more robust financial performance and stability before increasing their stakes in a company.
Outlook, Risks, and Final Insight
Moving forward, Hindustan Agrigenetics Ltd faces multiple challenges, particularly regarding profitability and operational efficiency. The company needs to enhance its revenue generation capabilities while managing costs effectively to improve its operating margins. The lack of debt provides some cushioning, but the need for strategic initiatives to boost sales remains paramount. Risks include continued low sales volumes, operational inefficiencies leading to negative profit margins, and the potential for further dilution of promoter stakes, which may affect investor confidence. Conversely, the company’s healthy liquidity position and increasing shareholder base may provide a foundation for future growth if it can pivot towards more effective management strategies. In scenarios where operational improvements are realized, there lies potential for recovery and investment interest; however, without significant changes, the company risks stagnation in a competitive sector.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors of Hindustan Agrigenetics Ltd
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Nagarjuna Agri Tech Ltd | 38.0 Cr. | 40.6 | 83.3/29.4 | 7.19 | 0.00 % | 1.34 % | 1.34 % | 10.0 | |
| Hindustan Agrigenetics Ltd | 25.9 Cr. | 58.9 | 103/47.4 | 648 | 0.00 % | 3.53 % | 3.61 % | 10.0 | |
| Elegant Floriculture & Agrotech (India) Ltd | 13.6 Cr. | 5.28 | 11.6/4.38 | 4.54 | 9.16 | 0.00 % | 5.85 % | 5.22 % | 10.0 |
| Industry Average | 0 Cr | 34.93 | 326.27 | 8.18 | 0.00% | 3.57% | 3.39% | 10.00 |
Quarterly Result
| Metric | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 0.04 | 0.00 | 0.03 | 0.00 | 0.04 | 0.00 | 0.03 | 0.00 | 0.04 | 0.00 | 0.03 | 0.00 | 0.04 |
| Expenses | 0.33 | 0.05 | 0.11 | 0.12 | 0.03 | 0.07 | -0.06 | 0.01 | 0.01 | 0.00 | 0.24 | 0.69 | 0.14 |
| Operating Profit | -0.29 | -0.05 | -0.08 | -0.12 | 0.01 | -0.07 | 0.09 | -0.01 | 0.03 | 0.00 | -0.21 | -0.69 | -0.10 |
| OPM % | -725.00% | -266.67% | 25.00% | 300.00% | 75.00% | -700.00% | -250.00% | ||||||
| Other Income | 0.09 | 0.14 | 0.15 | 0.03 | 0.14 | 0.16 | 0.15 | 0.15 | 0.02 | 0.15 | 0.24 | 0.18 | 0.51 |
| Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 |
| Profit before tax | -0.20 | 0.09 | 0.07 | -0.09 | 0.15 | 0.08 | 0.23 | 0.13 | 0.04 | 0.14 | 0.02 | -0.52 | 0.40 |
| Tax % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Net Profit | -0.20 | 0.09 | 0.07 | -0.09 | 0.15 | 0.07 | 0.22 | 0.13 | 0.04 | 0.14 | 0.02 | -0.52 | 0.40 |
| EPS in Rs |
Last Updated: August 19, 2025, 1:50 pm
Below is a detailed analysis of the quarterly data for Hindustan Agrigenetics Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:
- For Sales, as of Jun 2025, the value is 0.04 Cr.. The value appears strong and on an upward trend. It has increased from 0.00 Cr. (Mar 2025) to 0.04 Cr., marking an increase of 0.04 Cr..
- For Expenses, as of Jun 2025, the value is 0.14 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 0.69 Cr. (Mar 2025) to 0.14 Cr., marking a decrease of 0.55 Cr..
- For Operating Profit, as of Jun 2025, the value is -0.10 Cr.. The value appears strong and on an upward trend. It has increased from -0.69 Cr. (Mar 2025) to -0.10 Cr., marking an increase of 0.59 Cr..
- For OPM %, as of Jun 2025, the value is -250.00%. The value appears to be declining and may need further review. It has decreased from 0.00% (Mar 2025) to -250.00%, marking a decrease of 250.00%.
- For Other Income, as of Jun 2025, the value is 0.51 Cr.. The value appears strong and on an upward trend. It has increased from 0.18 Cr. (Mar 2025) to 0.51 Cr., marking an increase of 0.33 Cr..
- For Interest, as of Jun 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
- For Depreciation, as of Jun 2025, the value is 0.01 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.01 Cr..
- For Profit before tax, as of Jun 2025, the value is 0.40 Cr.. The value appears strong and on an upward trend. It has increased from -0.52 Cr. (Mar 2025) to 0.40 Cr., marking an increase of 0.92 Cr..
- For Tax %, as of Jun 2025, the value is 0.00%. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00%.
- For Net Profit, as of Jun 2025, the value is 0.40 Cr.. The value appears strong and on an upward trend. It has increased from -0.52 Cr. (Mar 2025) to 0.40 Cr., marking an increase of 0.92 Cr..
- For EPS in Rs, as of Jun 2025, the value is 0.00. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: October 15, 2025, 3:08 am
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 0.06 | 0.06 | 0.06 | 0.06 | 0.05 | 0.06 | 0.19 | 0.06 | 0.06 | 0.07 | 0.07 | 0.08 | 0.07 |
| Expenses | 0.12 | 0.26 | 0.12 | 0.16 | 0.21 | 0.22 | 0.59 | 0.19 | 0.23 | 0.71 | 0.37 | 1.10 | 1.07 |
| Operating Profit | -0.06 | -0.20 | -0.06 | -0.10 | -0.16 | -0.16 | -0.40 | -0.13 | -0.17 | -0.64 | -0.30 | -1.02 | -1.00 |
| OPM % | -100.00% | -333.33% | -100.00% | -166.67% | -320.00% | -266.67% | -210.53% | -216.67% | -283.33% | -914.29% | -428.57% | -1,275.00% | -1,428.57% |
| Other Income | 0.05 | 0.30 | 0.95 | 0.28 | 0.19 | 0.04 | 0.04 | -0.05 | 0.06 | 10.55 | 0.96 | 0.76 | 1.08 |
| Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.02 | 0.01 | 0.00 |
| Depreciation | 0.02 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.00 | 0.00 | 0.00 | 0.04 | 0.04 | 0.04 |
| Profit before tax | -0.03 | 0.09 | 0.88 | 0.17 | 0.02 | -0.13 | -0.37 | -0.18 | -0.11 | 9.91 | 0.60 | -0.31 | 0.04 |
| Tax % | 133.33% | 0.00% | 25.00% | 35.29% | 3,100.00% | -7.69% | -186.49% | -16.67% | -9.09% | 0.50% | 23.33% | 0.00% | |
| Net Profit | -0.07 | 0.09 | 0.66 | 0.11 | -0.59 | -0.12 | 0.33 | -0.15 | -0.10 | 9.86 | 0.47 | -0.31 | 0.04 |
| EPS in Rs | |||||||||||||
| Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
YoY Net Profit Growth
| Year | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | 228.57% | 633.33% | -83.33% | -636.36% | 79.66% | 375.00% | -145.45% | 33.33% | 9960.00% | -95.23% | -165.96% |
| Change in YoY Net Profit Growth (%) | 0.00% | 404.76% | -716.67% | -553.03% | 716.02% | 295.34% | -520.45% | 178.79% | 9926.67% | -10055.23% | -70.72% |
Hindustan Agrigenetics Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.
No data available for the compounded sales growth chart.
Balance Sheet
Last Updated: October 10, 2025, 4:16 pm
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 4.40 | 4.40 | 4.40 | 4.40 | 4.40 | 4.40 | 4.40 | 4.40 | 4.40 | 4.40 | 4.40 | 4.40 |
| Reserves | -2.44 | -2.35 | -1.69 | -1.63 | -2.22 | -2.48 | -2.16 | -2.30 | -2.40 | 7.46 | 7.93 | 7.62 |
| Borrowings | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Liabilities | 0.98 | 1.01 | 0.23 | 0.15 | 0.16 | 0.22 | 0.28 | 0.85 | 6.19 | 0.50 | 0.42 | 0.38 |
| Total Liabilities | 2.94 | 3.06 | 2.94 | 2.92 | 2.34 | 2.14 | 2.52 | 2.95 | 8.19 | 12.36 | 12.75 | 12.40 |
| Fixed Assets | 0.36 | 0.36 | 0.35 | 0.34 | 0.35 | 0.36 | 0.36 | 0.35 | 0.35 | 0.05 | 0.19 | 0.16 |
| CWIP | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Investments | 1.35 | 1.45 | 1.57 | 1.58 | 1.59 | 1.38 | 0.21 | 1.35 | 1.75 | 0.85 | 1.97 | 3.64 |
| Other Assets | 1.23 | 1.25 | 1.02 | 1.00 | 0.40 | 0.40 | 1.95 | 1.25 | 6.09 | 11.46 | 10.59 | 8.60 |
| Total Assets | 2.94 | 3.06 | 2.94 | 2.92 | 2.34 | 2.14 | 2.52 | 2.95 | 8.19 | 12.36 | 12.75 | 12.40 |
Below is a detailed analysis of the balance sheet data for Hindustan Agrigenetics Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:
- For Equity Capital, as of Mar 2025, the value is 4.40 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 4.40 Cr..
- For Reserves, as of Mar 2025, the value is 7.62 Cr.. The value appears to be declining and may need further review. It has decreased from 7.93 Cr. (Mar 2024) to 7.62 Cr., marking a decrease of 0.31 Cr..
- For Borrowings, as of Mar 2025, the value is 0.00 Cr.. The value remains steady. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. There is no change compared to the previous period (Mar 2024) which recorded 0.00 Cr..
- For Other Liabilities, as of Mar 2025, the value is 0.38 Cr.. The value appears to be improving (decreasing). It has decreased from 0.42 Cr. (Mar 2024) to 0.38 Cr., marking a decrease of 0.04 Cr..
- For Total Liabilities, as of Mar 2025, the value is 12.40 Cr.. The value appears to be improving (decreasing). It has decreased from 12.75 Cr. (Mar 2024) to 12.40 Cr., marking a decrease of 0.35 Cr..
- For Fixed Assets, as of Mar 2025, the value is 0.16 Cr.. The value appears to be declining and may need further review. It has decreased from 0.19 Cr. (Mar 2024) to 0.16 Cr., marking a decrease of 0.03 Cr..
- For CWIP, as of Mar 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 0.00 Cr..
- For Investments, as of Mar 2025, the value is 3.64 Cr.. The value appears strong and on an upward trend. It has increased from 1.97 Cr. (Mar 2024) to 3.64 Cr., marking an increase of 1.67 Cr..
- For Other Assets, as of Mar 2025, the value is 8.60 Cr.. The value appears to be declining and may need further review. It has decreased from 10.59 Cr. (Mar 2024) to 8.60 Cr., marking a decrease of 1.99 Cr..
- For Total Assets, as of Mar 2025, the value is 12.40 Cr.. The value appears to be declining and may need further review. It has decreased from 12.75 Cr. (Mar 2024) to 12.40 Cr., marking a decrease of 0.35 Cr..
Notably, the Reserves (7.62 Cr.) exceed the Borrowings (0.00 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow - No data available for this post.
Free Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | -0.06 | -0.20 | -0.06 | -0.10 | -0.16 | -0.16 | -0.40 | -0.13 | -0.17 | -0.64 | -0.30 | -1.02 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Inventory Days | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||
| Days Payable | ||||||||||||
| Cash Conversion Cycle | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Working Capital Days | -5,170.83 | -5,353.33 | -730.00 | -243.33 | -365.00 | -608.33 | 883.68 | -4,501.67 | -36,925.83 | -1,668.57 | 730.00 | 11,543.12 |
| ROCE % | -3.51% | -2.00% | 33.61% | 0.00% | 0.81% | -1.95% | -13.46% | -5.99% | -7.80% | 144.88% | 2.07% | -3.53% |
This stock is not held by any mutual fund.
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Basic EPS (Rs.) | -0.69 | 1.07 | 22.40 | -0.22 | -0.33 |
| Diluted EPS (Rs.) | -0.69 | 1.07 | 22.40 | -0.22 | -0.33 |
| Cash EPS (Rs.) | -0.61 | 1.15 | 22.41 | -0.21 | -0.32 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 27.32 | 27.65 | 26.58 | 4.17 | 4.39 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 27.32 | 28.02 | 26.95 | 4.55 | 4.77 |
| Revenue From Operations / Share (Rs.) | 0.17 | 2.35 | 24.43 | 0.28 | 0.13 |
| PBDIT / Share (Rs.) | -0.59 | 1.46 | 22.52 | -0.24 | -0.40 |
| PBIT / Share (Rs.) | -0.68 | 1.38 | 22.52 | -0.25 | -0.40 |
| PBT / Share (Rs.) | -0.69 | 1.38 | 22.52 | -0.25 | -0.40 |
| Net Profit / Share (Rs.) | -0.69 | 1.07 | 22.40 | -0.22 | -0.33 |
| PBDIT Margin (%) | -342.41 | 62.20 | 92.19 | -85.45 | -288.85 |
| PBIT Margin (%) | -388.97 | 58.64 | 92.17 | -87.40 | -295.28 |
| PBT Margin (%) | -399.09 | 58.64 | 92.17 | -87.40 | -295.28 |
| Net Profit Margin (%) | -395.59 | 45.44 | 91.71 | -76.62 | -238.42 |
| Return on Networth / Equity (%) | -2.53 | 3.85 | 84.29 | -5.28 | -7.52 |
| Return on Capital Employeed (%) | -2.42 | 4.91 | 83.54 | -5.53 | -8.59 |
| Return On Assets (%) | -2.45 | 3.68 | 79.74 | -1.18 | -4.94 |
| Asset Turnover Ratio (%) | 0.01 | 0.08 | 1.05 | 0.02 | 0.02 |
| Current Ratio (X) | 330.73 | 27.72 | 22.40 | 1.11 | 1.92 |
| Quick Ratio (X) | 330.73 | 27.72 | 22.40 | 1.11 | 1.92 |
| Interest Coverage Ratio (X) | -23.78 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Coverage Ratio (Post Tax) (X) | -26.77 | 0.00 | 0.00 | 0.00 | 0.00 |
| Enterprise Value (Cr.) | 24.41 | 13.01 | -8.02 | 0.00 | 0.00 |
| EV / Net Operating Revenue (X) | 316.56 | 12.59 | -0.74 | 0.00 | 0.00 |
| EV / EBITDA (X) | -92.45 | 20.24 | -0.80 | 0.00 | 0.00 |
| MarketCap / Net Operating Revenue (X) | 383.23 | 21.77 | 0.20 | 0.00 | 0.00 |
| Price / BV (X) | 2.46 | 1.85 | 0.19 | 0.00 | 0.00 |
| Price / Net Operating Revenue (X) | 383.71 | 21.77 | 0.20 | 0.00 | 0.00 |
| EarningsYield | -0.01 | 0.02 | 4.44 | 0.00 | 0.00 |
After reviewing the key financial ratios for Hindustan Agrigenetics Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
- For Basic EPS (Rs.), as of Mar 25, the value is -0.69. This value is below the healthy minimum of 5. It has decreased from 1.07 (Mar 24) to -0.69, marking a decrease of 1.76.
- For Diluted EPS (Rs.), as of Mar 25, the value is -0.69. This value is below the healthy minimum of 5. It has decreased from 1.07 (Mar 24) to -0.69, marking a decrease of 1.76.
- For Cash EPS (Rs.), as of Mar 25, the value is -0.61. This value is below the healthy minimum of 3. It has decreased from 1.15 (Mar 24) to -0.61, marking a decrease of 1.76.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 27.32. It has decreased from 27.65 (Mar 24) to 27.32, marking a decrease of 0.33.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 27.32. It has decreased from 28.02 (Mar 24) to 27.32, marking a decrease of 0.70.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 0.17. It has decreased from 2.35 (Mar 24) to 0.17, marking a decrease of 2.18.
- For PBDIT / Share (Rs.), as of Mar 25, the value is -0.59. This value is below the healthy minimum of 2. It has decreased from 1.46 (Mar 24) to -0.59, marking a decrease of 2.05.
- For PBIT / Share (Rs.), as of Mar 25, the value is -0.68. This value is below the healthy minimum of 0. It has decreased from 1.38 (Mar 24) to -0.68, marking a decrease of 2.06.
- For PBT / Share (Rs.), as of Mar 25, the value is -0.69. This value is below the healthy minimum of 0. It has decreased from 1.38 (Mar 24) to -0.69, marking a decrease of 2.07.
- For Net Profit / Share (Rs.), as of Mar 25, the value is -0.69. This value is below the healthy minimum of 2. It has decreased from 1.07 (Mar 24) to -0.69, marking a decrease of 1.76.
- For PBDIT Margin (%), as of Mar 25, the value is -342.41. This value is below the healthy minimum of 10. It has decreased from 62.20 (Mar 24) to -342.41, marking a decrease of 404.61.
- For PBIT Margin (%), as of Mar 25, the value is -388.97. This value is below the healthy minimum of 10. It has decreased from 58.64 (Mar 24) to -388.97, marking a decrease of 447.61.
- For PBT Margin (%), as of Mar 25, the value is -399.09. This value is below the healthy minimum of 10. It has decreased from 58.64 (Mar 24) to -399.09, marking a decrease of 457.73.
- For Net Profit Margin (%), as of Mar 25, the value is -395.59. This value is below the healthy minimum of 5. It has decreased from 45.44 (Mar 24) to -395.59, marking a decrease of 441.03.
- For Return on Networth / Equity (%), as of Mar 25, the value is -2.53. This value is below the healthy minimum of 15. It has decreased from 3.85 (Mar 24) to -2.53, marking a decrease of 6.38.
- For Return on Capital Employeed (%), as of Mar 25, the value is -2.42. This value is below the healthy minimum of 10. It has decreased from 4.91 (Mar 24) to -2.42, marking a decrease of 7.33.
- For Return On Assets (%), as of Mar 25, the value is -2.45. This value is below the healthy minimum of 5. It has decreased from 3.68 (Mar 24) to -2.45, marking a decrease of 6.13.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 0.01. It has decreased from 0.08 (Mar 24) to 0.01, marking a decrease of 0.07.
- For Current Ratio (X), as of Mar 25, the value is 330.73. This value exceeds the healthy maximum of 3. It has increased from 27.72 (Mar 24) to 330.73, marking an increase of 303.01.
- For Quick Ratio (X), as of Mar 25, the value is 330.73. This value exceeds the healthy maximum of 2. It has increased from 27.72 (Mar 24) to 330.73, marking an increase of 303.01.
- For Interest Coverage Ratio (X), as of Mar 25, the value is -23.78. This value is below the healthy minimum of 3. It has decreased from 0.00 (Mar 24) to -23.78, marking a decrease of 23.78.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is -26.77. This value is below the healthy minimum of 3. It has decreased from 0.00 (Mar 24) to -26.77, marking a decrease of 26.77.
- For Enterprise Value (Cr.), as of Mar 25, the value is 24.41. It has increased from 13.01 (Mar 24) to 24.41, marking an increase of 11.40.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 316.56. This value exceeds the healthy maximum of 3. It has increased from 12.59 (Mar 24) to 316.56, marking an increase of 303.97.
- For EV / EBITDA (X), as of Mar 25, the value is -92.45. This value is below the healthy minimum of 5. It has decreased from 20.24 (Mar 24) to -92.45, marking a decrease of 112.69.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 383.23. This value exceeds the healthy maximum of 3. It has increased from 21.77 (Mar 24) to 383.23, marking an increase of 361.46.
- For Price / BV (X), as of Mar 25, the value is 2.46. This value is within the healthy range. It has increased from 1.85 (Mar 24) to 2.46, marking an increase of 0.61.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 383.71. This value exceeds the healthy maximum of 3. It has increased from 21.77 (Mar 24) to 383.71, marking an increase of 361.94.
- For EarningsYield, as of Mar 25, the value is -0.01. This value is below the healthy minimum of 5. It has decreased from 0.02 (Mar 24) to -0.01, marking a decrease of 0.03.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Hindustan Agrigenetics Ltd:
- Net Profit Margin: -395.59%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: -2.42% (Industry Average ROCE: 3.57%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: -2.53% (Industry Average ROE: 3.39%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): -26.77
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 330.73
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 648 (Industry average Stock P/E: 326.27)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: -395.59%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Floriculture | 806, Meghdoot, 94, Nehru Place, New Delhi Delhi 110019 | hindustanagrigenetics@gmail.com http://www.hindustanagrigenetics.co.in |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Pranav Kapur | Chairman |
| Mr. Pritam Kapur | Director |
| Ms. Chandni Kapur | Director & CFO |
| Ms. Mannu Kohli | Director |
| Mr. Sunny Srivastava | Independent Director |
| Mr. Naren Parsai | Independent Director |
| Mr. Ravi Shankar Kolathur | Independent Director |
FAQ
What is the latest intrinsic value of Hindustan Agrigenetics Ltd?
The latest intrinsic value of Hindustan Agrigenetics Ltd is 0.00. Unfortunately, additional data is unavailable.
What is the Market Cap of Hindustan Agrigenetics Ltd?
The Market Cap of Hindustan Agrigenetics Ltd is 25.9 Cr..
What is the current Stock Price of Hindustan Agrigenetics Ltd as on 03 November 2025?
The current stock price of Hindustan Agrigenetics Ltd as on 03 November 2025 is 58.9.
What is the High / Low of Hindustan Agrigenetics Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Hindustan Agrigenetics Ltd stocks is 103/47.4.
What is the Stock P/E of Hindustan Agrigenetics Ltd?
The Stock P/E of Hindustan Agrigenetics Ltd is 648.
What is the Book Value of Hindustan Agrigenetics Ltd?
The Book Value of Hindustan Agrigenetics Ltd is .
What is the Dividend Yield of Hindustan Agrigenetics Ltd?
The Dividend Yield of Hindustan Agrigenetics Ltd is 0.00 %.
What is the ROCE of Hindustan Agrigenetics Ltd?
The ROCE of Hindustan Agrigenetics Ltd is 3.53 %.
What is the ROE of Hindustan Agrigenetics Ltd?
The ROE of Hindustan Agrigenetics Ltd is 3.61 %.
What is the Face Value of Hindustan Agrigenetics Ltd?
The Face Value of Hindustan Agrigenetics Ltd is 10.0.